Key result
Mayo Clinic risk factors did not significantly predict the need for vascular reconstruction (P=0.788), whereas hepatic vein involvement was a significant predictor of renal cell carcinoma-specific mortality.
Why the study?
Do preoperative radiologic indicators predict the need for vascular reconstruction and mortality in patients undergoing IVC thrombectomy for renal cell carcinoma?
Cohort (n=37)
Yes
Do preoperative radiologic indicators predict the need for vascular reconstruction and mortality in patients undergoing IVC thrombectomy for renal cell carcinoma?
Hepatic vein involvement on preoperative imaging is a significant predictor of accelerated mortality in patients undergoing IVC thrombectomy for renal cell carcinoma, whereas Mayo Clinic risk factors did not predict the need for vascular reconstruction in this cohort.
Answers are grounded in this paper and cite their sources.
Hepatic vein involvement was associated with higher RCC mortality after thrombectomy; hypothesis-generating and leaves Mayo risk factors unvalidated for reconstruction needs.
BACKGROUND: Renal cancer may invade the inferior vena cava (IVC) creating more complex surgical intervention. We investigate radiologic findings that may predict vascular reconstruction prior to surgery and future renal cancer-specific mortality. MATERIALS AND METHODS: Radiologic findings included Mayo Clinic risk factors for vascular reconstruction: Right-sided tumor, anteroposterior diameter of the IVC at the ostium of the renal vein ≥24.0 mm, and radiologic identification of complete occlusion of the IVC. Additional factors included thrombus in the lumen of the hepatic veins and metastasis. Along with other demographic factors, analysis included Chi-squared analysis for vascular reconstruction and logistic regression for mortality. A Kaplan-Meier curve was created for the most significant radiologic factor. RESULTS: Thirty-seven patients underwent IVC tumor thrombectomy at two institutions from April 2007 to February 2015. We found that Mayo risk factors of 0, 1, 2, and 3 and the proportions of vascular reconstruction of 0%, 0%, 12.5%, and 13.6%, respectively (P = 0.788). Hepatic vein involvement was the most significant determinate of renal cell carcinoma-specific mortality in multivariable analysis, controlling for the size of IVC at the hepatic veins, pulmonary metastasis, and Fuhrman grade (P = 0.02, Log-rank P = 0.002). CONCLUSION: Mayo risk factors did not predict vascular reconstruction in our small cohort of Level II-Level IV IVC thrombus undergoing IVC thrombectomy. Tumor thrombus traveling into the lumen of the hepatic veins was a significant risk factor for accelerated mortality.
No takes yet. Share an insight, caveat, or question.
Overholser et al. (2016) conducted a cohort in Renal cell carcinoma with inferior vena cava involvement (n=37). Mayo Clinic risk factors for vascular reconstruction vs. Absence of risk factors was evaluated on Need for inferior vena cava reconstruction at the time of surgery (p=0.788). Mayo Clinic risk factors did not significantly predict the need for vascular reconstruction (P=0.788), whereas hepatic vein involvement was a significant predictor of renal cell carcinoma-specific mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: